Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Resurrecting clinical pharmacology as a context for Alzheimer disease drug development.

Becker RE, Unni LK, Greig NH.

Curr Alzheimer Res. 2009 Feb;6(1):79-81. Review.

2.

Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study.

Becker RE, Colliver JA, Markwell SJ, Moriearty PL, Unni LK, Vicari S.

Alzheimer Dis Assoc Disord. 1998 Mar;12(1):54-7.

PMID:
9539412
3.

Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease.

Becker RE, Colliver JA, Markwell SJ, Moriearty PL, Unni LK, Vicari S.

Alzheimer Dis Assoc Disord. 1996 Fall;10(3):124-31.

PMID:
8876775
4.

Oral administration of heptylphysostigmine in healthy volunteers: a preliminary study.

Unni LK, Radcliffe J, Latham G, Sunderland T, Martinez R, Potter W, Becker RE.

Methods Find Exp Clin Pharmacol. 1994 Jun;16(5):373-6.

PMID:
7934317
5.

Pharmacokinetics and pharmacodynamics of metrifonate in humans.

Unni LK, Womack C, Hannant ME, Becker RE.

Methods Find Exp Clin Pharmacol. 1994 May;16(4):285-9.

PMID:
8051989
6.
7.
8.

Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.

Somani SM, Gupta SK, Khalique A, Unni LK.

Drug Metab Dispos. 1991 May-Jun;19(3):655-60.

PMID:
1680633
9.

Kinetics of cholinesterase inhibition by eptastigmine in man.

Unni LK, Hutt V, Imbimbo BP, Becker RE.

Eur J Clin Pharmacol. 1991;41(1):83-4. No abstract available.

PMID:
1782985
10.
11.

Drug interaction for plasma protein binding: physostigmine and other drugs.

Somani SM, Unni LK, McFadden DL.

Int J Clin Pharmacol Ther Toxicol. 1987 Aug;25(8):412-6.

PMID:
3654032
12.

Hepatic and muscle clearance of physostigmine in the rat.

Unni LK, Somani SM.

Drug Metab Dispos. 1986 Mar-Apr;14(2):183-9.

PMID:
2870892
13.

Inhibition of bovine brain monoamine oxidase by lead.

Unni LK, Caspers ML.

Biochem Pharmacol. 1985 Jul 15;34(14):2563-6. No abstract available.

PMID:
3925955
14.

Binding of physostigmine to rat and human plasma and crystalline serum albumins.

Unni LK, Somani SM.

Life Sci. 1985 Apr 8;36(14):1389-96.

PMID:
3982219
15.

Inhibition of bovine plasma amine oxidase by lead.

Unni LK, Caspers ML.

Biochem Pharmacol. 1984 Jul 1;33(13):2149-51. No abstract available.

PMID:
6430301

Supplemental Content

Support Center